Article
Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis.
Journal of gastroenterology and hepatology - 1 Jun 2015
Zhou Hua-ying, Luo Yue, Chen Wen-dong, Gong Guo-zhong
Abstract excerpt
BACKGROUND AND AIMS: A number of studies have confirmed that antiviral therapy with nucleotide analogs (NAs) can improve the prognosis of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after curative therapy. However, what factors affected the prognosis of HBV-HCC after removal of the primary tumor and inhibition of HBV replication? A meta-regression analysis was conducted to explore the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
